Fox Chase Cancer Center at Temple University Hospital has earned accreditation from the National Accreditation Program for Breast Centers (NAPBC) at the American College of Surgeons. To earn this prestigious accreditation, Fox Chase Cancer Center at Temple University Hospital’s breast cancer program met rigorous NAPBC standards for clinical services, research, community outreach, professional education, and quality improvement for patients, and will undergo a site visit every three years.
“Earning NAPBC accreditation signifies the commitment that our talented clinicians demonstrate in delivering comprehensive, patient-centered, multidisciplinary care, resulting in the very best treatment for patients with breast disease,” said Abhi Rastogi, MBA, MIS, President & CEO of Temple University Hospital and EVP of Temple University Health System.
“Fox Chase Cancer Center at Temple University Hospital’s exceptional breast cancer program provides our patients with advanced technology and diagnosis; the latest cancer treatment options; clinical trials; genetic counseling; and patient-centered services including psychosocial support, rehabilitation services, and survivorship care—all with the combined expertise and resources of Temple University Hospital and Fox Chase Cancer Center, two of Philadelphia’s most respected healthcare providers,” said Sukhmani Padda, MD, Vice Chair of Medical Oncology at Fox Chase Cancer Center at Temple University Hospital.
The accreditation process was led by Mary T. Pronovost, MD, Breast Surgical Director for Fox Chase Cancer Center at Temple University Hospital, who worked with the multidisciplinary team to surpass the rigorous standards required for accreditation, and to ensure Temple provides the highest-quality care. Fox Chase Cancer Center at Temple University Hospital’s accreditation complements the nearly two decade history of Fox Chase Cancer Center’s accreditation by NAPBC.